RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Elizabeth Mannick RTI Expert Headshot

Elizabeth Mannick

Director, Regulatory Affairs, Regulatory Strategy and Project Development


MD, Yale University School of Medicine
MS, Harvard School of Public Health
BA, Harvard College

Dr. Elizabeth Mannick is a physician with more than 20 years of experience in clinical medicine (pediatric and adult gastroenterology) practicing in urban academic and rural private practice settings. She also has 6 years of combined experience in the Food and Drug Administration and in regulatory affairs and drug safety in the pharmaceutical industry. Dr. Mannick has reviewed and spearheaded the filing of Investigational New Drug Applications (INDs), Clinical Trial Applications (CTAs), Biologics License Applications and New Drug Applications (NDAs).  

While at RTI, Dr. Mannick has worked on a variety of projects with government agencies including NIH, ARPA-H, CMS and BARDA as well as consulting for start-up companies.  

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics